BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16274043)

  • 1. [Comparison of pBcl-2 and pBax expression in primary invasive ductal pancreatic cancer between Chinese and Japanese patients].
    Zhou JP; Dong M; Nio Y; Kong FM; Zheng XY; Guo KJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):611-4. PubMed ID: 16274043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis and expression of Bcl-2 and Bax proteins in invasive ductal carcinoma of the pancreas.
    Nio Y; Iguchi C; Yamasawa K; Sasaki S; Takamura M; Toga T; Dong M; Itakura M; Tamura K
    Pancreas; 2001 Apr; 22(3):230-9. PubMed ID: 11291923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological significance of Bcl-2 and Bax protein expression in human pancreatic cancer.
    Dong M; Zhou JP; Zhang H; Guo KJ; Tian YL; Dong YT
    World J Gastroenterol; 2005 May; 11(18):2744-7. PubMed ID: 15884114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expressions of p53 and Gadd45a proteins in human pancreatic cancer and their clinicopathological significance].
    Dong M; Zhou JP; Kong FM; Guo KJ; Tian YL; Dong YT
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):628-32. PubMed ID: 16274047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of retinoblastoma and p53 pathway-related proteins in resectable invasive ductal carcinoma of the pancreas: potential cooperative effects on clinical outcome.
    Hashimoto K; Nio Y; Koike M; Itakura M; Yano S; Higami T; Maruyama R
    Anticancer Res; 2005; 25(2B):1361-8. PubMed ID: 15865092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of receptor-tyrosine kinase c-kit protein and TGF-beta1 in invasive ductal carcinoma of the pancreas.
    Nio Y; Omori H; Hashimoto K; Itakura M; Koike M; Yano S; Toga T; Higami T; Maruyama R
    Anticancer Res; 2005; 25(5):3523-9. PubMed ID: 16101174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protein expression of p53, bcl-2, and bax in adenoid cystic carcinoma of lacrimal gland].
    You JQ; Wang P
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1978-82. PubMed ID: 19062739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
    Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Yamamoto E
    J Oral Pathol Med; 2008 Jul; 37(6):364-71. PubMed ID: 18410312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the bcl-2 gene and its significance in human pancreatic carcinoma.
    Sun CY; Wang BL; Hu CQ; Peng RY; Gao YB; Gu QY; Wang DW
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):306-8. PubMed ID: 14612291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki-ras point mutation and p53 expression in human pancreatic cancer: a comparative study among Chinese, Japanese, and Western patients.
    Dong M; Nio Y; Tamura K; Song MM; Guo KJ; Guo RX; Dong YT
    Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):279-84. PubMed ID: 10750666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Bcl-2 and p53 protein in resectable invasive ductal carcinoma of the pancreas: effects on clinical outcome and efficacy of adjuvant chemotherapy.
    Nio Y; Dong M; Iguchi C; Yamasawa K; Toga T; Itakura M; Tamura K
    J Surg Oncol; 2001 Mar; 76(3):188-96. PubMed ID: 11276023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma.
    Zhang M; Zhang P; Zhang C; Sun J; Wang L; Li J; Tian Z; Chen W
    J Oral Pathol Med; 2009 Mar; 38(3):307-13. PubMed ID: 18710422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of the genes FHIT, Bcl-2 and Bax in breast infiltrating ductal carcinoma and clinicopathological significance thereof].
    Wang ZB; Zhao P; Liu M; Li XH
    Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(31):2171-6. PubMed ID: 17064501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical features.
    Nishikawa N; Kimura Y; Okita K; Zembutsu H; Furuhata T; Katsuramaki T; Kimura S; Asanuma H; Hirata K
    J Hepatobiliary Pancreat Surg; 2006; 13(4):327-35. PubMed ID: 16858545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of c-kit protein expression in pancreatic neoplasms and its implication for prognosis.
    Kimura W; Ma J; Takeshita A; Yamamoto T; Moriya T; Hirai I; Fuse A
    Hepatogastroenterology; 2007 Dec; 54(80):2203-8. PubMed ID: 18265633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dissociated expression of protein and messenger RNA of DPC4 in human invasive ductal carcinoma of the pancreas and their implication for patient outcome.
    Toga T; Nio Y; Hashimoto K; Higami T; Maruyama R
    Anticancer Res; 2004; 24(2C):1173-8. PubMed ID: 15154643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
    Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
    Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Bcl-2 but not Bax has a prognostic significance in tongue carcinoma.
    de Vicente JC; Olay S; Lequerica-Fernandez P; Sánchez-Mayoral J; Junquera LM; Fresno MF
    J Oral Pathol Med; 2006 Mar; 35(3):140-5. PubMed ID: 16454809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
    Liang JJ; Wang H; Rashid A; Tan TH; Hwang RF; Hamilton SR; Abbruzzese JL; Evans DB; Wang H
    Clin Cancer Res; 2008 Nov; 14(21):7043-9. PubMed ID: 18981001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Gadd45a and p53 proteins in human pancreatic cancer: potential effects on clinical outcomes.
    Dong M; Dong Q; Zhang H; Zhou J; Tian Y; Dong Y
    J Surg Oncol; 2007 Mar; 95(4):332-6. PubMed ID: 17230496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.